The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A
The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1 reverse transcriptase (RT). Seven RTs mutated at am...
Gespeichert in:
Veröffentlicht in: | Molecular pharmacology 2005-09, Vol.68 (3), p.652-659 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 659 |
---|---|
container_issue | 3 |
container_start_page | 652 |
container_title | Molecular pharmacology |
container_volume | 68 |
creator | Auwerx, Joeri Rodríguez-Barrios, Fátima Ceccherini-Silberstein, Francesca San-Félix, Ana Velázquez, Sonsoles De Clercq, Erik Camarasa, María-José Perno, Carlo-Federico Gago, Federico Balzarini, Jan |
description | The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from
tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1
reverse transcriptase (RT). Seven RTs mutated at amino acid position 139 (Ala, Lys, Tyr, Asp, Ile, Ser, and Gln) were constructed
by site-directed mutagenesis. The mutant T139Q enzyme retained full catalytic activity compared with wild-type RT, whereas
the mutant T139I, T139S, and T139A RTs retained only 85 to 50% of the activity. Mutant T139K, T139D, and T139Y RTs had seriously
impaired catalytic activities. The mutations in the T139I and T139D RTs were shown to destabilize the RT heterodimer. (+)-Calanolide
A lost inhibitory activity (up to 20-fold) against the mutant T139Y, T139Q, T139K, and T139I enzymes. All of the mutant enzymes
retained marked susceptibility toward the other NNRTIs, including nevirapine, delavirdine, efavirenz, thiocarboxanilide UC-781,
quinoxaline GW867420X, TSAO [[2â²,5â²-bis- O -( tert -butyldimethylsilyl)-β- d -ribofuranosyl]-3â²-spiro-5â³-(4â³-amino-1â³,2â³-oxathiole-2â³,2â³-dioxide)] derivatives, and the nucleoside inhibitor, ddGTP. The
fact that the T139I RT 1) proved to be resistant to (+)-calanolide A, 2) represents a catalytically efficient enzyme, and
3) requires only a single transition point mutation (ACAâATA) in codon 139 seems to explain why mutant T139I RT virus strains,
but not virus strains containing other amino acid changes at this position, predominantly emerge in cell cultures under (+)-calanolide
A pressure. |
doi_str_mv | 10.1124/mol.105.012351 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17405258</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17405258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-e7de38949ae8b159b96817175927056e1e208010050f92a04a4b7d8e959f13ac3</originalsourceid><addsrcrecordid>eNpFkM-L1TAQx4Mo7nP16lFyURTpcyZt2uS4PNRdWBDWKt5CXjvdRtqmm7Qr_e-NvAee5gefGb58GHuNsEcUxafRD3sEuQcUucQnbIdSYAaI-JTtAESZKS1_XbAXMf4GwEIqeM4uUOoSy6rYsVj3xO_8QNx3vO4D5pq7iS9pe72OduI347hOvqXONY6mZuM_XVgjr7eZOPI7eqQQidfBTrEJbl5smr7TFN3iHt2y8cXz9x8_ZAc72MkPriV-9ZI96-wQ6dW5XrIfXz7Xh-vs9tvXm8PVbdbkslgyqlrKlS60JXVMiY-6VFhhJbWoQJaEJEABAkjotLBQ2OJYtYq01B3mtskv2bvT3zn4h5XiYkYXGxpSEvJrNFgVIIVUCdyfwCb4GAN1Zg5utGEzCOafZpM0p16ak-Z08Ob8eT2O1P7Hz14T8PYE9O6-_-MCmbm3YbSNH_z9ZkplclNKkf8FoTiD7Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17405258</pqid></control><display><type>article</type><title>The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Auwerx, Joeri ; Rodríguez-Barrios, Fátima ; Ceccherini-Silberstein, Francesca ; San-Félix, Ana ; Velázquez, Sonsoles ; De Clercq, Erik ; Camarasa, María-José ; Perno, Carlo-Federico ; Gago, Federico ; Balzarini, Jan</creator><creatorcontrib>Auwerx, Joeri ; Rodríguez-Barrios, Fátima ; Ceccherini-Silberstein, Francesca ; San-Félix, Ana ; Velázquez, Sonsoles ; De Clercq, Erik ; Camarasa, María-José ; Perno, Carlo-Federico ; Gago, Federico ; Balzarini, Jan</creatorcontrib><description>The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from
tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1
reverse transcriptase (RT). Seven RTs mutated at amino acid position 139 (Ala, Lys, Tyr, Asp, Ile, Ser, and Gln) were constructed
by site-directed mutagenesis. The mutant T139Q enzyme retained full catalytic activity compared with wild-type RT, whereas
the mutant T139I, T139S, and T139A RTs retained only 85 to 50% of the activity. Mutant T139K, T139D, and T139Y RTs had seriously
impaired catalytic activities. The mutations in the T139I and T139D RTs were shown to destabilize the RT heterodimer. (+)-Calanolide
A lost inhibitory activity (up to 20-fold) against the mutant T139Y, T139Q, T139K, and T139I enzymes. All of the mutant enzymes
retained marked susceptibility toward the other NNRTIs, including nevirapine, delavirdine, efavirenz, thiocarboxanilide UC-781,
quinoxaline GW867420X, TSAO [[2â²,5â²-bis- O -( tert -butyldimethylsilyl)-β- d -ribofuranosyl]-3â²-spiro-5â³-(4â³-amino-1â³,2â³-oxathiole-2â³,2â³-dioxide)] derivatives, and the nucleoside inhibitor, ddGTP. The
fact that the T139I RT 1) proved to be resistant to (+)-calanolide A, 2) represents a catalytically efficient enzyme, and
3) requires only a single transition point mutation (ACAâATA) in codon 139 seems to explain why mutant T139I RT virus strains,
but not virus strains containing other amino acid changes at this position, predominantly emerge in cell cultures under (+)-calanolide
A pressure.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.105.012351</identifier><identifier>PMID: 15961674</identifier><language>eng</language><publisher>United States: American Society for Pharmacology and Experimental Therapeutics</publisher><subject>Coumarins - pharmacology ; HIV Reverse Transcriptase - antagonists & inhibitors ; HIV Reverse Transcriptase - chemistry ; HIV Reverse Transcriptase - genetics ; Human immunodeficiency virus 1 ; Kinetics ; Models, Molecular ; Mutagenesis, Site-Directed ; Pyranocoumarins ; Reverse Transcriptase Inhibitors - pharmacology ; Threonine - chemistry ; Threonine - physiology</subject><ispartof>Molecular pharmacology, 2005-09, Vol.68 (3), p.652-659</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-e7de38949ae8b159b96817175927056e1e208010050f92a04a4b7d8e959f13ac3</citedby><cites>FETCH-LOGICAL-c354t-e7de38949ae8b159b96817175927056e1e208010050f92a04a4b7d8e959f13ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15961674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Auwerx, Joeri</creatorcontrib><creatorcontrib>Rodríguez-Barrios, Fátima</creatorcontrib><creatorcontrib>Ceccherini-Silberstein, Francesca</creatorcontrib><creatorcontrib>San-Félix, Ana</creatorcontrib><creatorcontrib>Velázquez, Sonsoles</creatorcontrib><creatorcontrib>De Clercq, Erik</creatorcontrib><creatorcontrib>Camarasa, María-José</creatorcontrib><creatorcontrib>Perno, Carlo-Federico</creatorcontrib><creatorcontrib>Gago, Federico</creatorcontrib><creatorcontrib>Balzarini, Jan</creatorcontrib><title>The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from
tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1
reverse transcriptase (RT). Seven RTs mutated at amino acid position 139 (Ala, Lys, Tyr, Asp, Ile, Ser, and Gln) were constructed
by site-directed mutagenesis. The mutant T139Q enzyme retained full catalytic activity compared with wild-type RT, whereas
the mutant T139I, T139S, and T139A RTs retained only 85 to 50% of the activity. Mutant T139K, T139D, and T139Y RTs had seriously
impaired catalytic activities. The mutations in the T139I and T139D RTs were shown to destabilize the RT heterodimer. (+)-Calanolide
A lost inhibitory activity (up to 20-fold) against the mutant T139Y, T139Q, T139K, and T139I enzymes. All of the mutant enzymes
retained marked susceptibility toward the other NNRTIs, including nevirapine, delavirdine, efavirenz, thiocarboxanilide UC-781,
quinoxaline GW867420X, TSAO [[2â²,5â²-bis- O -( tert -butyldimethylsilyl)-β- d -ribofuranosyl]-3â²-spiro-5â³-(4â³-amino-1â³,2â³-oxathiole-2â³,2â³-dioxide)] derivatives, and the nucleoside inhibitor, ddGTP. The
fact that the T139I RT 1) proved to be resistant to (+)-calanolide A, 2) represents a catalytically efficient enzyme, and
3) requires only a single transition point mutation (ACAâATA) in codon 139 seems to explain why mutant T139I RT virus strains,
but not virus strains containing other amino acid changes at this position, predominantly emerge in cell cultures under (+)-calanolide
A pressure.</description><subject>Coumarins - pharmacology</subject><subject>HIV Reverse Transcriptase - antagonists & inhibitors</subject><subject>HIV Reverse Transcriptase - chemistry</subject><subject>HIV Reverse Transcriptase - genetics</subject><subject>Human immunodeficiency virus 1</subject><subject>Kinetics</subject><subject>Models, Molecular</subject><subject>Mutagenesis, Site-Directed</subject><subject>Pyranocoumarins</subject><subject>Reverse Transcriptase Inhibitors - pharmacology</subject><subject>Threonine - chemistry</subject><subject>Threonine - physiology</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM-L1TAQx4Mo7nP16lFyURTpcyZt2uS4PNRdWBDWKt5CXjvdRtqmm7Qr_e-NvAee5gefGb58GHuNsEcUxafRD3sEuQcUucQnbIdSYAaI-JTtAESZKS1_XbAXMf4GwEIqeM4uUOoSy6rYsVj3xO_8QNx3vO4D5pq7iS9pe72OduI347hOvqXONY6mZuM_XVgjr7eZOPI7eqQQidfBTrEJbl5smr7TFN3iHt2y8cXz9x8_ZAc72MkPriV-9ZI96-wQ6dW5XrIfXz7Xh-vs9tvXm8PVbdbkslgyqlrKlS60JXVMiY-6VFhhJbWoQJaEJEABAkjotLBQ2OJYtYq01B3mtskv2bvT3zn4h5XiYkYXGxpSEvJrNFgVIIVUCdyfwCb4GAN1Zg5utGEzCOafZpM0p16ak-Z08Ob8eT2O1P7Hz14T8PYE9O6-_-MCmbm3YbSNH_z9ZkplclNKkf8FoTiD7Q</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Auwerx, Joeri</creator><creator>Rodríguez-Barrios, Fátima</creator><creator>Ceccherini-Silberstein, Francesca</creator><creator>San-Félix, Ana</creator><creator>Velázquez, Sonsoles</creator><creator>De Clercq, Erik</creator><creator>Camarasa, María-José</creator><creator>Perno, Carlo-Federico</creator><creator>Gago, Federico</creator><creator>Balzarini, Jan</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20050901</creationdate><title>The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A</title><author>Auwerx, Joeri ; Rodríguez-Barrios, Fátima ; Ceccherini-Silberstein, Francesca ; San-Félix, Ana ; Velázquez, Sonsoles ; De Clercq, Erik ; Camarasa, María-José ; Perno, Carlo-Federico ; Gago, Federico ; Balzarini, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-e7de38949ae8b159b96817175927056e1e208010050f92a04a4b7d8e959f13ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Coumarins - pharmacology</topic><topic>HIV Reverse Transcriptase - antagonists & inhibitors</topic><topic>HIV Reverse Transcriptase - chemistry</topic><topic>HIV Reverse Transcriptase - genetics</topic><topic>Human immunodeficiency virus 1</topic><topic>Kinetics</topic><topic>Models, Molecular</topic><topic>Mutagenesis, Site-Directed</topic><topic>Pyranocoumarins</topic><topic>Reverse Transcriptase Inhibitors - pharmacology</topic><topic>Threonine - chemistry</topic><topic>Threonine - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Auwerx, Joeri</creatorcontrib><creatorcontrib>Rodríguez-Barrios, Fátima</creatorcontrib><creatorcontrib>Ceccherini-Silberstein, Francesca</creatorcontrib><creatorcontrib>San-Félix, Ana</creatorcontrib><creatorcontrib>Velázquez, Sonsoles</creatorcontrib><creatorcontrib>De Clercq, Erik</creatorcontrib><creatorcontrib>Camarasa, María-José</creatorcontrib><creatorcontrib>Perno, Carlo-Federico</creatorcontrib><creatorcontrib>Gago, Federico</creatorcontrib><creatorcontrib>Balzarini, Jan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Auwerx, Joeri</au><au>Rodríguez-Barrios, Fátima</au><au>Ceccherini-Silberstein, Francesca</au><au>San-Félix, Ana</au><au>Velázquez, Sonsoles</au><au>De Clercq, Erik</au><au>Camarasa, María-José</au><au>Perno, Carlo-Federico</au><au>Gago, Federico</au><au>Balzarini, Jan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>68</volume><issue>3</issue><spage>652</spage><epage>659</epage><pages>652-659</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from
tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1
reverse transcriptase (RT). Seven RTs mutated at amino acid position 139 (Ala, Lys, Tyr, Asp, Ile, Ser, and Gln) were constructed
by site-directed mutagenesis. The mutant T139Q enzyme retained full catalytic activity compared with wild-type RT, whereas
the mutant T139I, T139S, and T139A RTs retained only 85 to 50% of the activity. Mutant T139K, T139D, and T139Y RTs had seriously
impaired catalytic activities. The mutations in the T139I and T139D RTs were shown to destabilize the RT heterodimer. (+)-Calanolide
A lost inhibitory activity (up to 20-fold) against the mutant T139Y, T139Q, T139K, and T139I enzymes. All of the mutant enzymes
retained marked susceptibility toward the other NNRTIs, including nevirapine, delavirdine, efavirenz, thiocarboxanilide UC-781,
quinoxaline GW867420X, TSAO [[2â²,5â²-bis- O -( tert -butyldimethylsilyl)-β- d -ribofuranosyl]-3â²-spiro-5â³-(4â³-amino-1â³,2â³-oxathiole-2â³,2â³-dioxide)] derivatives, and the nucleoside inhibitor, ddGTP. The
fact that the T139I RT 1) proved to be resistant to (+)-calanolide A, 2) represents a catalytically efficient enzyme, and
3) requires only a single transition point mutation (ACAâATA) in codon 139 seems to explain why mutant T139I RT virus strains,
but not virus strains containing other amino acid changes at this position, predominantly emerge in cell cultures under (+)-calanolide
A pressure.</abstract><cop>United States</cop><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>15961674</pmid><doi>10.1124/mol.105.012351</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0026-895X |
ispartof | Molecular pharmacology, 2005-09, Vol.68 (3), p.652-659 |
issn | 0026-895X 1521-0111 |
language | eng |
recordid | cdi_proquest_miscellaneous_17405258 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry |
subjects | Coumarins - pharmacology HIV Reverse Transcriptase - antagonists & inhibitors HIV Reverse Transcriptase - chemistry HIV Reverse Transcriptase - genetics Human immunodeficiency virus 1 Kinetics Models, Molecular Mutagenesis, Site-Directed Pyranocoumarins Reverse Transcriptase Inhibitors - pharmacology Threonine - chemistry Threonine - physiology |
title | The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T14%3A33%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Thr139%20in%20the%20Human%20Immunodeficiency%20Virus%20Type%201%20Reverse%20Transcriptase%20Sensitivity%20to%20(+)-Calanolide%20A&rft.jtitle=Molecular%20pharmacology&rft.au=Auwerx,%20Joeri&rft.date=2005-09-01&rft.volume=68&rft.issue=3&rft.spage=652&rft.epage=659&rft.pages=652-659&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.105.012351&rft_dat=%3Cproquest_cross%3E17405258%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17405258&rft_id=info:pmid/15961674&rfr_iscdi=true |